If you want to make your experience better during the early game of StarRupture, you can follow a specific order of unlocks ...

The Brief keeps Texas voters and political observers up to speed on the most essential coverage of their elected officials, the policies that shape their daily lives and the future of our great state.

Deciphering the Data is a side quest added to ARC Raiders in the winter-themed Cold Snap update. This quest sends you to the Spaceport to find some important data, but the objectives can be hard to ...

Amazon titan Jeff Bezos has put the final touches on his marital home -- and one of them seems plucked from another galaxy. Amazon titan Jeff Bezos has put the final touches on his marital home. New ...

Amid an outpouring of obesity data Monday, Wave Life Sciences and Structure Therapeutics were among the biotechs jockeying to set their weight loss assets apart in an increasingly crowded field as ...

Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron. Structure Therapeutics' stock soared toward an 18-month high in early Monday trading, after mid-stage data for its ...

What really happens after you hit enter on that AI prompt? WSJ’s Joanna Stern heads inside a data center to trace the journey and then grills up some steaks to show just how much energy it takes to ...

Ambuj Tewari receives funding from NSF and NIH. You’ve just finished a strenuous hike to the top of a mountain. You’re exhausted but elated. The view of the city below is gorgeous, and you want to ...

Business leaders are juggling more transformation efforts than ever. AI is dominating conversations now, but it's just one (albeit important) piece of a larger puzzle. We're being asked to modernize ...

Major corporations today dedicate millions to data lakes and data warehouses and data fabrics through advanced analytics systems that operate from on-premises and cloud environments. The process of ...

CULVER CITY, Calif.--(BUSINESS WIRE)-- ImmunityBio, Inc., a leading immunotherapy company, today announced early findings from the first five recurrent glioblastoma patients treated with its ...